JP2020510418A5 - - Google Patents

Info

Publication number

JP2020510418A5

JP2020510418A5 JP2019545322A JP2019545322A JP2020510418A5 JP 2020510418 A5 JP2020510418 A5 JP 2020510418A5 JP 2019545322 A JP2019545322 A JP 2019545322A JP 2019545322 A JP2019545322 A JP 2019545322A JP 2020510418 A5 JP2020510418 A5 JP 2020510418A5

Authority

JP

Japan

Prior art keywords

seq

tfr

animal

polypeptide

apical domain

Prior art date

2018-02-15

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108010033576 Transferrin Receptors Proteins 0.000 claims description 70
• 102000007238 Transferrin Receptors Human genes 0.000 claims description 65
• 238000000034 method Methods 0.000 claims description 57
• 229920001184 polypeptide Polymers 0.000 claims description 54
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 54
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 54
• 241001465754 Metazoa Species 0.000 claims description 50
• 210000004027 cell Anatomy 0.000 claims description 39
• 230000009261 transgenic effect Effects 0.000 claims description 34
• 239000012636 effector Substances 0.000 claims description 24
• 108091033319 polynucleotide Proteins 0.000 claims description 24
• 102000040430 polynucleotide Human genes 0.000 claims description 24
• 239000002157 polynucleotide Substances 0.000 claims description 24
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 22
• 210000001161 mammalian embryo Anatomy 0.000 claims description 16
• 210000004556 brain Anatomy 0.000 claims description 15
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 11
• 150000007523 nucleic acids Chemical group 0.000 claims description 11
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 9
• 239000000427 antigen Substances 0.000 claims description 9
• 102000036639 antigens Human genes 0.000 claims description 9
• 108091007433 antigens Proteins 0.000 claims description 9
• 239000012634 fragment Substances 0.000 claims description 9
• 239000002773 nucleotide Substances 0.000 claims description 9
• 125000003729 nucleotide group Chemical group 0.000 claims description 9
• 108020004414 DNA Proteins 0.000 claims description 8
• 230000000694 effects Effects 0.000 claims description 6
• 102000004338 Transferrin Human genes 0.000 claims description 5
• 108090000901 Transferrin Proteins 0.000 claims description 5
• 230000003285 pharmacodynamic effect Effects 0.000 claims description 5
• 239000012581 transferrin Substances 0.000 claims description 5
• 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 4
• 230000008499 blood brain barrier function Effects 0.000 claims description 4
• 210000001218 blood-brain barrier Anatomy 0.000 claims description 4
• 150000003384 small molecules Chemical class 0.000 claims description 4
• 241000283984 Rodentia Species 0.000 claims description 3
• 238000012216 screening Methods 0.000 claims description 3
• 108091033409 CRISPR Proteins 0.000 claims description 2
• 108091026890 Coding region Proteins 0.000 claims description 2
• 108091027544 Subgenomic mRNA Proteins 0.000 claims description 2
• 210000005013 brain tissue Anatomy 0.000 claims description 2
• 238000012217 deletion Methods 0.000 claims description 2
• 230000037430 deletion Effects 0.000 claims description 2
• 239000003814 drug Substances 0.000 claims description 2
• 229940079593 drug Drugs 0.000 claims description 2
• 210000001671 embryonic stem cell Anatomy 0.000 claims description 2
• 230000006801 homologous recombination Effects 0.000 claims description 2
• 238000002744 homologous recombination Methods 0.000 claims description 2
• 238000012544 monitoring process Methods 0.000 claims description 2
• 101000835089 Mus musculus Transferrin receptor protein 1 Proteins 0.000 claims 5
• 102000001554 Hemoglobins Human genes 0.000 claims 2
• 108010054147 Hemoglobins Proteins 0.000 claims 2
• 210000002257 embryonic structure Anatomy 0.000 claims 2
• 238000005534 hematocrit Methods 0.000 claims 2
• 241000894007 species Species 0.000 claims 2
• 238000006467 substitution reaction Methods 0.000 claims 2
• 238000004820 blood count Methods 0.000 claims 1
• 210000003743 erythrocyte Anatomy 0.000 claims 1
• 210000003734 kidney Anatomy 0.000 claims 1
• 210000004185 liver Anatomy 0.000 claims 1
• 210000004072 lung Anatomy 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 238000005259 measurement Methods 0.000 claims 1
• 108090000623 proteins and genes Proteins 0.000 claims 1
• 101100369221 Mus musculus Tfrc gene Proteins 0.000 description 5
• 238000003018 immunoassay Methods 0.000 description 4
• 210000003038 endothelium Anatomy 0.000 description 3
• 238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 2
• 108700024394 Exon Proteins 0.000 description 1
• 101000766306 Homo sapiens Serotransferrin Proteins 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• 101000766305 Mus musculus Serotransferrin Proteins 0.000 description 1
• 239000003795 chemical substances by application Substances 0.000 description 1
• 238000001727 in vivo Methods 0.000 description 1
• XNSAINXGIQZQOO-SRVKXCTJSA-N protirelin Chemical compound NC(=O)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)[C@H]1NC(=O)CC1)CC1=CN=CN1 XNSAINXGIQZQOO-SRVKXCTJSA-N 0.000 description 1